V024-2817 Screening compound: N-[(1-benzyl-2-phenylmethanesulfonyl-1H-imidazol-5-yl)methyl]-2-methyl-N-(2-methylpropyl)benzamide

V024-2817 Screening compound: N-[(1-benzyl-2-phenylmethanesulfonyl-1H-imidazol-5-yl)methyl]-2-methyl-N-(2-methylpropyl)benzamide
V024-2817 Screening compound: N-[(1-benzyl-2-phenylmethanesulfonyl-1H-imidazol-5-yl)methyl]-2-methyl-N-(2-methylpropyl)benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V024-2817
N-[(1-benzyl-2-phenylmethanesulfonyl-1H-imidazol-5-yl)methyl]-2-methyl-N-(2-methylpropyl)benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V024-2817

Molecular Formula

C30H33N3O3S (C30 H33 N3 O3 S)

Compound Name

N-[(1-benzyl-2-phenylmethanesulfonyl-1H-imidazol-5-yl)methyl]-2-methyl-N-(2-methylpropyl)benzamide

IUPAC name

N-[(1-benzyl-2-phenylmethanesulfonyl-1H-imidazol-5-yl)methyl]-2-methyl-N-(2-methylpropyl)benzamide

SMILES

CC(C)CN(Cc(n1Cc2ccccc2)cnc1S(Cc1ccccc1)(=O)=O)C(c1c(C)cccc1)=O

InChI

InChI=1S/C30H33N3O3S/c1-23(2)19-32(29(34)28-17-11-10-12-24(28)3)21-27-18-31-30(33(27)20-25-13-6-4-7-14-25)37(35,36)22-26-15-8-5-9-16-26/h4-18,23H,19-22H2,1-3H3

InChI Key

AKFCQTPRSSCNIL-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19824844

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

515.68

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

5.342

Distribution Coefficient, logD

5.342

Water Solubility, LogSw

-5.22

Polar Surface Area

56.863

Acid Dissociation Constant (pKa)

20.02

Base Dissociation Constant (pKb)

-3.30

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

26.70

V024-2817 in Drug Discovery

Included in Screening Libraries

CORONAVIRUS Library (20774 compounds)

KRAS-Targeted Library (16000 compounds)

?ysteine Targeted Covalent Library (39471 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with V024-2817 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V024-2817?
Check Price and Availability of V024-2817, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V024-2817 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V024-2817
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V024-2817
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V024-2817 available by request